TCL Archive Single-Agent Phase III Trial Comparing Vectibix to Erbitux Meets Primary Endpoint May 31, 2013
TCL Archive Medicare to cut payments for cancer drugs by 2-8%. ASCO estimates total cut in reimbursement at $500 million. July 30, 2004
TCL Archive Wall Street Analyst Who Sounded Alarm Over Prostate Cancer Drug Provenge In JNCI Settles With SEC Over Shorting Dendreon Stock December 17, 2013
TCL Archive Competing Strategies For Breast Cancer? Brinker Tries to Ensure acceptance Of Report, Visco Urges Broad Effort October 8, 1993
TCL Archive ECG Disputes Accrual Figures Cited By DeVita, Says Numbers Are Up 17% This Year And Still Rising July 8, 1988
